Study Overview The study aimed to investigate the design and effectiveness of an asynchronous online course developed specifically for concussion […]
Study Overview This study investigates the phenomenon of tumefactive demyelinating disorders, which can often masquerade as neoplasms on imaging studies.
Background and Rationale Ocrelizumab is a monoclonal antibody approved for the treatment of primary progressive multiple sclerosis (PPMS) and relapsing
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »
Understanding Frontotemporal Dementia Frontotemporal dementia (FTD) represents a group of disorders that primarily affect the frontal and temporal lobes of
Background on Pseudohypacusis Pseudohypacusis, often referred to as non-organic hearing loss, poses a unique challenge in audiology. It describes a
Cognitive Dysfunctions Cognitive dysfunctions in Parkinson’s disease (PD) encompass a range of impairments that extend beyond the well-documented motor symptoms.
Patient Presentation A 28-year-old man presented to the emergency department with complaints of a severe headache that had been persisting
Case 21-2026: A 28-Year-Old Man with Headache and Vision Loss in the Right Eye Read Post »
Ocrelizumab and Colitis Risk Ocrelizumab is a monoclonal antibody primarily utilized in the treatment of multiple sclerosis (MS) and certain
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »
Study Overview This study centers on a unique case of diffuse midline glioma, characterized by the H3K27M mutation, identified during
Clinical Presentation Pseudohypacusis, commonly referred to as non-organic hearing loss, presents a unique challenge in clinical settings. Individuals may exhibit
